AeroGen, Inc. (AEGN) Gain Approval for Entry into Chinese Market
2/17/2012 7:05:23 AM
GALWAY, Ireland--(BUSINESS WIRE)--Aerogen,(www.aerogen.com) the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China. The Aeroneb Pro is a patented vibrating mesh nebuliser which creates a fine particle aerosol for targeted drug delivery to the lungs. This unique, easy to use, multi-patient nebuliser is aimed predominately at the critical care market for treatment of a broad spectrum of patient respiratory conditions. Aerogen has also received approval for its home care device, the Aeroneb Go. Based on the same vibrating mesh technology, the Aeroneb Go brings hospital grade efficiency to inhaled drug treatment in the home.
comments powered by